We are live on
!
Find out more
SC
Savant Capital Portfolio holdings
AUM
$20.7B
1-Year Est. Return
19.76%
This Fund
S&P 500
This Quarter
Est. Return
-1.78%
1 Year Est. Return
+19.76%
3 Year Est. Return
+51.75%
5 Year Est. Return
+48.44%
10 Year Est. Return
+194.21%
AUM
$12.7B
AUM Growth
+$674M
(+5.6%)
Cap. Flow
+$981M
Cap. Flow
% of AUM
7.71%
Top 10 Holdings %
Top 10 Hldgs %
38.66%
Holding
1,528
New
147
Increased
695
Reduced
524
Closed
106
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional International High Profitability ETF
DIHP
|
+$184M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$97.9M |
| 3 |
Dimensional US Large Cap Value ETF
DFLV
|
+$83.1M |
| 4 |
Avantis Emerging Markets Equity ETF
AVEM
|
+$73M |
| 5 |
Avantis International Small Cap Value ETF
AVDV
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$29.3M |
| 2 |
Leuthold Core ETF
LCR
|
+$25M |
| 3 |
Dimensional US Marketwide Value ETF
DFUV
|
+$23.7M |
| 4 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$20.9M |
| 5 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$19.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.72% |
| 2 | Financials | 3.1% |
| 3 | Consumer Discretionary | 2.64% |
| 4 | Industrials | 2.52% |
| 5 | Healthcare | 2.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Yext
YEXT
$547M
| $105K | ﹤0.01% |
16,512
-544
| -3% | -$3.95K |
|
1377
MiMedx Group
MDXG
$602M
| $99.9K | ﹤0.01% |
+10,380
| New | +$80.9K |
|
|
FINV
1378
FinVolution Group
FINV
$1.15B
| $98.9K | ﹤0.01% |
14,567
+747
| +5% | +$4.8K |
|
1379
Portillo's
PTLO
$331M
| $96.1K | ﹤0.01% |
+10,221
| New | +$117K |
|
1380
Garrett Motion
GTX
$5.81B
| $95.5K | ﹤0.01% |
+10,577
| New | +$87.8K |
|
1381
Teekay
TK
$1.01B
| $94.9K | ﹤0.01% |
+13,700
| New | +$106K |
|
1382
Sasol
SSL
$7.5B
| $94.3K | ﹤0.01% |
+20,681
| New | +$117K |
|
1383
Lloyds Banking Group
LYG
$89.5B
| $89.7K | ﹤0.01% |
32,987
-8,532
| -21% | -$24.4K |
|
|
TERN
1384
DELISTED
Terns Pharmaceuticals
TERN
| $89.1K | ﹤0.01% |
+16,083
| New | +$109K |
|
1385
PUT
Microsoft
MSFT
$3.45T
| – | – |
0
| – | – |
|
|
ONL
1386
Orion Office REIT
ONL
$150M
| $83.9K | ﹤0.01% |
22,616
+18
| +0.1% | +$71 |
|
1387
BioCryst Pharmaceuticals
BCRX
$2.28B
| $79.6K | ﹤0.01% |
10,585
-11,477
| -52% | -$87.1K |
|
|
SFIX
1388
Stitch Fix
SFIX
$536M
| $79.5K | ﹤0.01% |
+18,444
| New | +$67.9K |
|
|
TEF
1389
DELISTED
Telefonica
TEF
| $79.2K | ﹤0.01% |
19,704
-9,378
| -32% | -$42.2K |
|
1390
iHeartMedia
IHRT
$543M
| $78.1K | ﹤0.01% |
39,426
-2
| -0% | -$4 |
|
1391
PUT
Apple
AAPL
$4.54T
| – | – |
0
| – | – |
|
1392
Xeris Biopharma Holdings
XERS
$1.39B
| $75K | ﹤0.01% |
22,116
+1
| +0% | +$3 |
|
1393
Baytex Energy
BTE
$3.25B
| $73.2K | ﹤0.01% |
28,380
-25,932
| -48% | -$73.6K |
|
1394
Zentalis Pharmaceuticals
ZNTL
$337M
| $72.4K | ﹤0.01% |
+23,893
| New | +$78.3K |
|
1395
Vanda Pharmaceuticals
VNDA
$307M
| $72.3K | ﹤0.01% |
15,094
-204
| -1% | -$979 |
|
1396
Wipro
WIT
$19.6B
| $67.6K | ﹤0.01% |
+19,100
| New | +$65.4K |
|
|
OLPX
1397
DELISTED
Olaplex Holdings
OLPX
| $67.5K | ﹤0.01% |
39,004
+3
| +0% | +$6 |
|
1398
United Microelectronic
UMC
$47.7B
| $66.3K | ﹤0.01% |
+10,223
| New | +$73.2K |
|
1399
Gabelli Equity Trust
GAB
$1.75B
| $66.2K | ﹤0.01% |
12,297
| – | – |
|
1400
SES AI
SES
$203M
| $65.7K | ﹤0.01% |
+30,000
| New | +$17.1K |
|
Similar funds
VARA
CB
MIC
GT
EWA
MMH
P
Savant Capital's Q4 2024 Portfolio in Review
As of Q4 2024, Savant Capital held 1,528 positions worth $12.7B, up 5.6% from $12B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Savant Capital deployed $981M of net new capital in Q4 2024, opening 147 new positions and adding to 695 existing holdings. Its largest new stake was iShares US Treasury Bond ETF: 891,825 shares worth $20.5M.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 5.1% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Dimensional US Core Equity 2 ETF, an estimated $29.3M trimmed.
- Savant Capital's largest Q4 2024 buy was iShares US Treasury Bond ETF: 891,825 shares worth $20.5M.
- Savant Capital added most to Dimensional International High Profitability ETF in Q4 2024, an estimated $184M increase.
- Savant Capital's biggest Q4 2024 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $29.3M.
- Savant Capital fully exited Leuthold Core ETF in Q4 2024, selling an estimated $25M.
- Savant Capital's ten largest holdings make up 39% of its $12.7B portfolio in Q4 2024.
- Savant Capital opened 147 new positions and closed 106 in Q4 2024.
- Savant Capital's portfolio value rose 5.6% quarter-over-quarter to $12.7B.
Based on Savant Capital's 13F filing for Q4 2024, filed 29 Jan 2025.